{"code":{"coding":[{"code":"55822004","display":"Hyperlipidemia (disorder)","system":"http://snomed.info/sct"}]},"date":"2019-05-26T10:44:00+10:00","definition":["https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf"],"description":"Hyperlipidemia Status","hasBodySite":false,"hasSeverity":false,"hasStage":false,"id":"example","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.4.642.25.1"}],"medication":[{"code":{"coding":[{"code":"203151","display":"Gemfibrozil","system":"http://www.nlm.nih.gov/research/umls/rxnorm"}]}}],"name":"Hyperlipidemia","observation":[{"code":{"coding":[{"code":"24331-1","display":"Lipid 1996 panel - Serum or Plasma","system":"http://loinc.org"}],"text":"Lipid Panel"}},{"code":{"coding":[{"code":"35200-5","display":"Cholesterol [Moles/​volume] in Serum or Plasma","system":"http://loinc.org"}],"text":"Cholesterol"}},{"code":{"coding":[{"code":"35217-9","display":"Triglyceride [Moles/​volume] in Serum or Plasma","system":"http://loinc.org"}],"text":"Triglyceride"}},{"code":{"coding":[{"code":"2085-9","display":"HDL Cholesterol","system":"http://loinc.org"}],"text":"Cholesterol in HDL"}},{"code":{"coding":[{"code":"13457-7","display":"Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation","system":"http://loinc.org"}],"text":"LDL Chol. (Calc)"}}],"plan":[{"reference":{"reference":"http://acme.com/fhir/PlanDefinition/fd0e32d8-2ebd-4211-9e50-8983efddc2c6"}}],"resourceType":"ConditionDefinition","status":"draft","text":{"div":"

Generated Narrative: ConditionDefinition

Resource ConditionDefinition "example"

url: http://hl7.org/fhir/ConditionDefinition/example

identifier: id:\u00a0urn:oid:2.16.840.1.113883.4.642.25.1

name: Hyperlipidemia

title: Hyperlipidemia Status

status: draft

date: 2019-05-26T10:44:00+10:00

description: Hyperlipidemia Status

code: Hyperlipidemia (disorder) (SNOMED CT#55822004)

hasSeverity: false

hasBodySite: false

hasStage: false

definition: https://med.stanford.edu/content/dam/sm/cerc/documents/Hyperlipidemia%20Management%20Protocol.pdf

observation

code: Lipid Panel (LOINC#24331-1 "Lipid 1996 panel - Serum or Plasma")

observation

code: Cholesterol (LOINC#35200-5 "Cholesterol [Moles/​volume] in Serum or Plasma")

observation

code: Triglyceride (LOINC#35217-9 "Triglyceride [Moles/​volume] in Serum or Plasma")

observation

code: Cholesterol in HDL (LOINC#2085-9 "HDL Cholesterol")

observation

code: LDL Chol. (Calc) (LOINC#13457-7 "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation")

Medications

-Code
*Gemfibrozil (RxNorm#203151)

Plans

-Reference
*http://acme.com/fhir/PlanDefinition/fd0e32d8-2ebd-4211-9e50-8983efddc2c6
","status":"generated"},"title":"Hyperlipidemia Status","url":"http://hl7.org/fhir/ConditionDefinition/example"}